News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Adds SH PHARMA (02607.HK) TP to $10.3, Lifts NP Forecasts
SH PHARMA (02607.HK)'s 4Q25 revenue was RMB68.5 billion, up 4.4% YoY, higher than Goldman Sachs' forecasted RMB65.9 billion, mainly driven by solid performance in its manuf...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Adds SH PHARMA (02607.HK) TP to $10.3, Lifts NP Forecasts
Close
Recommend
3
Positive
2
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

SH PHARMA (02607.HK)  0.000 (0.000%)    Short selling $3.50M; Ratio 7.093%   's 4Q25 revenue was RMB68.5 billion, up 4.4% YoY, higher than Goldman Sachs' forecasted RMB65.9 billion, mainly driven by solid performance in its manufacturing segment, according to Goldman Sachs' research report.

However, net profit for the same period amounted to RMB578 million, up 16% YoY, below the broker's estimation of RMB1.2 billion, mainly due to a substantial increase in selling expenses driven by the commercialization of innovative drugs, as well as investment losses and asset impairments recognized during the period.

Goldman Sachs raised its 2026-2027 net profit anticipations for SH PHARMA by 5.8%/ 1.7% each to reflect higher selling expenses and the consolidation of Shanghai Hutchison Pharmaceuticals, and introduced a 2028 EPS forecast of RMB1.06.

Therefore, the broker added its target price from $10.03 to $10.3, with rating kept at Sell.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-29 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.